Electroacupuncture Pretreatment Ameliorates PTSD-Like Behaviors in Rats by Enhancing Hippocampal Neurogenesis via the Keap1/Nrf2 Antioxidant Signaling Pathway.
electroacupuncture
hippocampus
keap1/Nrf2
post-traumatic stress disorder
pretreatment
Journal
Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935
Informations de publication
Date de publication:
2019
2019
Historique:
received:
17
01
2019
accepted:
06
06
2019
entrez:
12
7
2019
pubmed:
12
7
2019
medline:
12
7
2019
Statut:
epublish
Résumé
Electroacupuncture (EA) pretreatment is a clinically useful therapy for several brain disorders. However, whether and via which exact molecular mechanisms it ameliorates post-traumatic stress disorder (PTSD) remains unclear. In the present study, rats received EA stimulation for seven consecutive days before exposure to enhanced single prolonged stress (ESPS). Anxiety-like and fear learning behaviors; hippocampal neurogenesis; the expression of nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (keap1), and heme oxygenase 1 (HO-1); and the activity of AMP-activated kinase (AMPK) were evaluated at 14 days after ESPS. EA pretreatment improved hippocampal neurogenesis and ameliorated anxiety-like behaviors in ESPS-treated rats. EA pretreatment also increased the expression of Nrf2 and HO-1 and the activity of AMPK. Furthermore, Nrf2 knockdown by a short hairpin RNA affected anxiety-like behaviors and expression of neuroprotective markers (BDNF, DCX) in a manner similar to ESPS alone and dampened the neuroprotective effects of EA pretreatment. In contrast, Keap1 knockdown increased the expression of HO-1, improved hippocampal neurogenesis, and alleviated PTSD-like behaviors. Altogether, our results suggest that EA pretreatment ameliorates ESPS-induced anxiety-like behaviors and prevents hippocampal neurogenesis disruption in a rat model of PTSD possibly through regulation of the keap1/Nrf2 antioxidant defense pathway.
Identifiants
pubmed: 31293390
doi: 10.3389/fncel.2019.00275
pmc: PMC6598452
doi:
Types de publication
Journal Article
Langues
eng
Pagination
275Références
J Neurosci. 2001 Mar 1;21(5):1720-6
pubmed: 11222661
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Neurosci. 2003 Apr 15;23(8):3394-406
pubmed: 12716947
Biol Psychiatry. 2003 May 15;53(10):863-70
pubmed: 12742673
Anat Sci Int. 2003 Jun;78(2):69-78
pubmed: 12828419
Science. 2003 Dec 5;302(5651):1760-5
pubmed: 14615545
Hum Brain Mapp. 2005 Mar;24(3):193-205
pubmed: 15499576
J Neurosci. 2008 Dec 10;28(50):13574-81
pubmed: 19074031
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2933-8
pubmed: 19196989
Stroke. 2009 Jun;40(6):2157-64
pubmed: 19372445
Neuron. 2010 Jan 14;65(1):7-19
pubmed: 20152109
Oxid Med Cell Longev. 2009 Apr-Jun;2(2):63-7
pubmed: 20357926
Neurosci Lett. 2010 Jul 12;478(3):150-5
pubmed: 20457216
Chin J Integr Med. 2010 Jun;16(3):229-33
pubmed: 20694777
Cent Eur Neurosurg. 2011 Aug;72(3):133-7
pubmed: 20857373
Evid Based Complement Alternat Med. 2011;2011:180805
pubmed: 20976074
Brain Res. 2012 Jan 13;1432:36-45
pubmed: 22129788
Anesthesiology. 2012 Feb;116(2):406-14
pubmed: 22222470
J Neuroinflammation. 2012 Jan 26;9:24
pubmed: 22277256
J Vis Exp. 2012 May 24;(63):e4031
pubmed: 22664962
Front Oncol. 2012 Dec 26;2:200
pubmed: 23272301
Behav Brain Res. 2013 May 1;244:1-8
pubmed: 23384713
Neuron. 2013 Mar 6;77(5):955-68
pubmed: 23473324
Psychoneuroendocrinology. 2013 Oct;38(10):2010-22
pubmed: 23623252
Altern Ther Health Med. 2013 May-Jun;19(3):26-30
pubmed: 23709457
Neurochem Int. 2013 Oct;63(4):302-8
pubmed: 23831620
Brain Res. 2013 Sep 5;1529:154-64
pubmed: 23880371
PLoS One. 2013 Oct 09;8(10):e76146
pubmed: 24130763
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18291-6
pubmed: 24145448
Front Hum Neurosci. 2013 Nov 07;7:747
pubmed: 24223547
Biochim Biophys Acta. 2014 Aug;1842(8):1208-18
pubmed: 24382478
Mol Neurobiol. 2014 Oct;50(2):305-13
pubmed: 24390566
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:16-22
pubmed: 24418162
Hippocampus. 2014 Jul;24(7):751-61
pubmed: 24550158
Nat Rev Neurosci. 2014 Mar;15(3):181-92
pubmed: 24552786
Nat Commun. 2014 Mar 25;5:3496
pubmed: 24667209
Biol Psychiatry. 2015 Feb 15;77(4):375-84
pubmed: 24842116
J Mol Neurosci. 2015 Feb;55(2):492-9
pubmed: 25007950
PLoS One. 2014 Aug 12;9(8):e104924
pubmed: 25115759
Curr Opin Neurobiol. 2015 Feb;30:51-8
pubmed: 25240202
Mol Psychiatry. 2014 Nov;19(11):1156-62
pubmed: 25245500
Eur Neuropsychopharmacol. 2014 Dec;24(12):1925-44
pubmed: 25451698
Free Radic Biol Med. 2015 Feb;79:78-90
pubmed: 25483558
PLoS One. 2015 Feb 06;10(2):e0117189
pubmed: 25659132
Neuropsychopharmacology. 2015 Sep;40(10):2368-78
pubmed: 25833129
Nat Commun. 2015 May 13;6:7066
pubmed: 25967870
Cell Mol Neurobiol. 2015 Nov;35(8):1093-103
pubmed: 25976178
Stem Cell Rev. 2015 Oct;11(5):706-9
pubmed: 26100529
Brain Res. 2015 Oct 22;1624:398-404
pubmed: 26254730
PLoS One. 2015 Nov 02;10(11):e0141622
pubmed: 26524181
Free Radic Biol Med. 2015 Dec;89:1077-84
pubmed: 26546103
Mol Neurobiol. 2016 Dec;53(10):6680-6689
pubmed: 26650043
Nat Neurosci. 2016 Feb;19(2):283-9
pubmed: 26727549
Neurosci Lett. 2016 Feb 26;615:66-71
pubmed: 26773866
Cell. 2016 Jun 2;165(6):1361-1374
pubmed: 27259148
J Neurosci. 2016 Jun 8;36(23):6332-51
pubmed: 27277809
Cell Rep. 2016 Aug 9;16(6):1653-1663
pubmed: 27477270
J Neurosci. 2016 Aug 10;36(32):8441-52
pubmed: 27511015
Neurosci Biobehav Rev. 2016 Dec;71:48-57
pubmed: 27590828
Mol Psychiatry. 2017 Dec;22(12):1701-1713
pubmed: 27646262
Curr Psychiatry Rep. 2016 Nov;18(11):99
pubmed: 27671916
Brain Res Bull. 2016 Oct;127:248-259
pubmed: 27771396
Mol Psychiatry. 2018 Feb;23(2):362-374
pubmed: 27843149
Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14835-14840
pubmed: 27930324
Anesthesiology. 2017 Mar;126(3):507-521
pubmed: 28045693
JAMA Psychiatry. 2017 Mar 1;74(3):270-281
pubmed: 28055082
J Trauma Dissociation. 2018 Jan-Feb;19(1):39-58
pubmed: 28151093
JAMA Intern Med. 2017 Apr 1;177(4):508-515
pubmed: 28241154
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4676-E4685
pubmed: 28533375
Redox Biol. 2017 Oct;13:393-401
pubmed: 28667908
Neurochem Res. 2017 Nov;42(11):3073-3083
pubmed: 28780733
Int J Mol Sci. 2017 Aug 24;18(9):null
pubmed: 28837077
Nat Neurosci. 2017 Nov;20(11):1634-1642
pubmed: 28892057
Mol Med Rep. 2017 Nov;16(5):7305-7314
pubmed: 28944872
Exp Neurol. 2018 Feb;300:222-231
pubmed: 29199131
Eur Neuropsychopharmacol. 2018 Jan;28(1):63-74
pubmed: 29224968
Nat Commun. 2018 Jan 19;9(1):298
pubmed: 29352183
Free Radic Biol Med. 2018 May 1;119:34-44
pubmed: 29374533
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:313-321
pubmed: 29596995
Biol Psychiatry. 2018 Oct 1;84(7):531-541
pubmed: 29605177
Neuropharmacology. 2018 Jun;135:514-528
pubmed: 29654801
Br J Pharmacol. 2018 Aug;175(16):3407-3421
pubmed: 29888782
Biomed Pharmacother. 2018 Oct;106:192-199
pubmed: 29958143
JAMA. 2018 Jul 10;320(2):167-176
pubmed: 29998338
J Neurotrauma. 2019 Mar 1;36(5):768-788
pubmed: 30032713
Br J Pharmacol. 2019 Jun;176(12):2079-2094
pubmed: 30825187